Search hospitals > Kansas > El Dorado

AMR El Dorado

Claim this profile
El Dorado, Kansas 67042
Conducts research for Type 2 Diabetes
Conducts research for Healthy Subjects
Conducts research for Flu
Conducts research for Obesity
Conducts research for Meningococcal Vaccination
6 reported clinical trials
0 medical researchers
Photo of AMR El Dorado in El DoradoPhoto of AMR El Dorado in El DoradoPhoto of AMR El Dorado in El Dorado

Summary

AMR El Dorado is a medical facility located in El Dorado, Kansas. This center is recognized for care of Type 2 Diabetes, Healthy Subjects, Flu, Obesity, Meningococcal Vaccination and other specialties. AMR El Dorado is involved with conducting 6 clinical trials across 13 conditions. There are 0 research doctors associated with this hospital, such as .

Top PIs

Clinical Trials running at AMR El Dorado

Type 2 Diabetes
Cardiovascular Disease
Obesity
Hypertension
High Blood Pressure
Bubonic Plague
Image of trial facility.

Naltrexone + Bupropion

for Obesity

This trial studies the effects of a medication combination (naltrexone and bupropion) on heart health. It targets patients to see if this treatment increases the risk of major heart problems. The study also includes advice on diet and exercise. Naltrexone and bupropion have been used in combination for weight loss, but they have been associated with various adverse effects, including neuropsychiatric disorders and cardiovascular risks.
Recruiting2 awards Phase 423 criteria
Image of trial facility.

Vicadrostat + Empagliflozin

for Type 2 Diabetes and Hypertension

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empagliflozin, helps reduce cardiovascular risk in people with these conditions. The study will compare this combination to a placebo version of vicadrostat with empagliflozin. Participants are put into 2 groups randomly, which means by chance. One group takes vicadrostat and empagliflozin tablets, and the other group takes placebo tablets with empagliflozin. Placebo tablets look like vicadrostat tablets but do not contain any medicine. Participants take a tablet once per day for 2 and a half years and up to 4 years and 3 months. All participants also continue their medication for type 2 diabetes, high blood pressure, and cardiovascular disease. Participants have an equal chance of receiving the study medicine or placebo. Participants are in the study for up to 4 years and 3 months. During this time, they visit the study site regularly. During these visits, doctors collect information about participants' health and take blood samples. The doctors document when participants experience cardiovascular events. The doctors also regularly check participants' health and take note of any unwanted effects.
Recruiting1 award Phase 34 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at AMR El Dorado?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security